Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly D Sullivan

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Nature Communications|October 20, 2019
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptorsRani K Powers, Rachel Culp-Hill, Michael P Ludwig, et al.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Cell Reports|November 14, 2019
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A Waugh, Paula Araya, Ahwan Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Elife|December 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Iscience|August 23, 2019
Multi-Omic Approaches Identify Metabolic and Autophagy Regulators Important in Ovarian Cancer DisseminationLindsay J Wheeler, Zachary L Watson, Lubna Qamar, et al.
Medrxiv : the Preprint Server for Health Sciences|December 17, 2020
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Elife|March 16, 2021
Seroconversion stages COVID19 into distinct pathophysiological statesMatthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Nature Communications|October 20, 2019
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptorsRani K Powers, Rachel Culp-Hill, Michael P Ludwig, et al.
Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.
Cell Reports|November 14, 2019
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down SyndromeKatherine A Waugh, Paula Araya, Ahwan Pandey, et al.
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Elife|December 31, 2024
JAK inhibition decreases the autoimmune burden in Down syndromeAngela L Rachubinski, Elizabeth Wallace, Emily Gurnee, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
The COVIDome Explorer Researcher PortalKelly D Sullivan, Matthew D Galbraith, Kohl T Kinning, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2022
Specialized interferon action in COVID-19Matthew D Galbraith, Kohl T Kinning, Kelly D Sullivan, et al.
Pageof 7